STAT

JULY 17, 2023

Doctors have long suspected that hearing loss in older adults hastens dementia, the cognitive decline associated with aging. A new study published in The Lancet on Tuesday probes the link between the two conditions further in what could be the first randomized controlled trial of its kind.  More than 55 million people have dementia worldwide; a number that continues to grow as more people live longer.

246

246

ALiEM - Pharm Pearls

JULY 17, 2023

The Study In an Annals of Emergency Medicine paper , Preiksaitis et al. sought to identify program factors associated with unfilled post-graduate year 1 (PGY-1) emergency medicine (EM) positions in the 2023 Match [1]. The authors completed a cross-sectional, observational study using National Residency Matching Program (NRMP) data and examined 9 variables as potential predictors of unfilled PGY1 positions using regression analyses [2].

Medical Schools 130

Medical Schools 130

STAT

JULY 17, 2023

Florida legislators recently passed legislation to prevent advanced practice nurses in Florida with doctorates from using the honorific “doctor.” The state House and Senate bills proposed that nurses with doctorates who introduce themselves to patients as “Dr. Smith, nurse practitioner,” could face disciplinary action. Lobbyists who supported this measure referred to it as a “patient empowerment bill that allows them to understand who is treating them.

246

246

PharmaVoice

JULY 17, 2023

A new toolkit developed by industry stakeholders paves the way for faster reviews.

130

130

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

JULY 17, 2023

The Food and Drug Administration approved a monoclonal antibody to protect infants and young children from severe illness caused by RSV on Monday, a potential game-changer for a disease that is the No. 1 cause of hospitalization of babies in this country. Use of the antibody treatment, the brand name for which is Beyfortus, still needs to be recommended by the Advisory Committee on Immunization Practices, an independent expert panel that advises the Centers for Disease Control and Prevention.

Immunity 246

Immunity Immunization Hospitals Vaccines 246

BioPharma Dive

JULY 17, 2023

For $500 million, Novartis will acquire DTx Pharma and its preclinical neurological disease drugs, marking the Swiss company’s latest investment in gene-silencing medicines.

98

98

Pharma Marketing Network

JULY 17, 2023

Amy Turnquist has more than 20 years of experience leading teams to create and deliver innovative, client-centric solutions that connect pharmaceutical brands with their HCP and consumer audiences. In her role as a Principal at North Highland, Amy helps healthcare organizations transform their engagement strategy, driving sustainable change and measurable impact by keeping people at the heart of every decision.

98

98

STAT

JULY 17, 2023

This is part of a series about new obesity drugs that are transforming patients’ lives, dividing medical experts, and spurring one of the biggest business battles in years. Read more about  The Obesity Revolution. LOS ANGELES — On this pleasant spring day, patients and uniformed health care workers crisscross the UCLA medical campus like ants on a picnic table.

235

235

BioPharma Dive

JULY 17, 2023

An organization of retinal specialists flagged six cases of severe eye inflammation from commercial use of Syfovre. Apellis says the drug’s safety profile is consistent with testing.

97

97

STAT

JULY 17, 2023

QuidelOrtho has recalled nearly 8,000 potentially faulty blood tests meant to help doctors quickly determine whether a patient is having a heart attack. The tests inaccurately showed low levels of troponin, a protein that indicates damage to the heart. A false negative could lead doctors to mistakenly conclude their patient is not having a heart attack, delaying diagnosis or treatment when time is of the essence.

Hospitals 216

Hospitals 216

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

PharmExec

JULY 17, 2023

In this Q&A, Craig Serra, head of commercial solutions and partnerships within the clinical research business unit at Flatiron Health (affiliate of the Roche Group), shares his perspective on clinical research, the role of data, and Flatiron Health’s efforts to that end.

97

97

STAT

JULY 17, 2023

Westlake Village BioPartners, a West Coast biotech venture capital firm founded five years ago by two Amgen veterans, has raised a new fund and brought in two veteran investors from another biotech VC as one of its founders takes a back seat. Westlake just raised $450 million for its third fund. It’s the first without the involvement of co-founder Sean Harper, who started the firm in 2018 with his Amgen colleague Beth Seidenberg.

215

215

Drug Patent Watch

JULY 17, 2023

Annual Drug Patent Expirations for IMBRUVICA Imbruvica is a drug marketed by Pharmacyclics Inc and is included in three NDAs. It is available from one supplier. There are fifty-five patents… The post New patent for Pharmacyclics Inc drug IMBRUVICA appeared first on DrugPatentWatch - Make Better Decisions.

96

96

STAT

JULY 17, 2023

Big businesses poised to profit from the advance of artificial intelligence in health care are pushing back against newly proposed federal rules meant to increase oversight and fairness of AI tools used to help make decisions about patient care. The opposition, which includes Google and Amazon as well as large health care providers, insurers, and medical software vendors, is focused on an attempt to put tighter guardrails around the use of AI by the Office of the National Coordinator for Health

214

214

BioPharma Dive

JULY 17, 2023

Leaders from the firm said that, despite a turbulent biotech market, most of their existing limited partners returned to participate in the new fund, which will support approximately a dozen startups.

94

94

STAT

JULY 17, 2023

At the turn of the century, nearly 18 million women in the United States were battling hot flashes, night sweats, and other symptoms of menopause with hormones. But in 2002, the therapy went into a free-fall when a landmark trial suggested treating menopause with estrogen and progesterone increased the risk of breast cancer and cardiovascular disease.

214

214

Pharma Times

JULY 17, 2023

OCTP develops cannabinoid medicines and is looking at potential treatment of cancer malignancies - News - PharmaTimes

111

111

STAT

JULY 17, 2023

The health records company NextGen Healthcare will pay $31 million to resolve allegations that it paid kickbacks to win customers and concealed shortcomings of its software to gain government certification. The settlement caps a lengthy investigation that cast a harsh light on NextGen’s efforts to gain market share in the sharp-elbowed business of selling electronic health records software.

Hospitals 204

Hospitals 204

European Pharmaceutical Review

JULY 17, 2023

A new three-year research programme led by researchers at Massachusetts Institute of Technology ( MIT ) is aiming to design the world’s first fully integrated, continuous mRNA manufacturing platform. The resulting pilot-scale system is intended to improve society’s ability to respond to future pandemics as well as accelerate the development and production of mRNA technologies.

Vaccines 93

Vaccines 93

STAT

JULY 17, 2023

Wyandanch is a proud, resilient community on Long Island. There’s about 13,000 people who live in this predominantly Black and brown hamlet. In early June, it celebrated its 55th annual Wyandanch Family Day. Hundreds of people lined the streets to watch a parade complete with floats, marching bands, and dancers. It was a blue, nearly cloudless day — much different than the hazy orange skies a few days earlier.

196

196

BioPharma Dive

JULY 17, 2023

Scribe will receive $40 million upfront from Sanofi in a collaboration initially focused on developing an in vivo gene editing treatment for sickle cell disease.

95

95

STAT

JULY 17, 2023

The latest clash over the cost of a prescription medicine is playing out in Colombia, where the government is exploring the possibility of issuing a compulsory license for a needed HIV treatment — a move that would spark another battle with the pharmaceutical industry. Last month, Colombian Health Minister Guillermo Alfonso Jaramillo issued a resolution to examine whether the government should pursue a license to obtain lower-cost generic versions of an HIV medicine called dolutegravir ma

Drug Pricing 189

Drug Pricing 189

European Pharmaceutical Review

JULY 17, 2023

Eli Lilly and Company’s TRAILBLAZER-ALZ 2 study has shown donanemab enabled nearly half of participants at earlier stage of Alzheimer’s to experience no clinical progression at one year, according to full results from the Phase III trial. The data was shared at the 2023 Alzheimer’s Association International Conference (AAIC) and published in the Journal of the American Medical Association (JAMA).

88

88

STAT

JULY 17, 2023

The benefits and risks of Eli Lilly’s treatment for Alzheimer’s disease were confirmed in detailed scientific disclosures Monday, paving the way for its full approval but leaving physicians with lingering questions about the medicine’s impact on patients as a new era in Alzheimer’s therapy unfolds. The drug, called donanemab, showed a 35% slowing of Alzheimer’s disease progression relative to placebo in a clinical trial that enrolled 1,700 patients with early-s

189

189

European Pharmaceutical Review

JULY 17, 2023

New research published in JAMA Health Forum has documented that the US National Institutes of Health (NIH) spent $8.1 billion for phased clinical trials of US Food and Drug Administration (FDA)-approved drugs between 2010-2019. This was ~10 percent of reported industry spending. T he article, written researchers at Bentley University, is the first to broadly assess NIH’s contribution to clinical development of new drugs and compare the scale of NIH spending relative to reported spending by ind

Documentation 86

Documentation 86

STAT

JULY 17, 2023

WASHINGTON — It’s two weeks until Congress leaves town in August, and a prominent House panel is throwing a wrench in what seemed like a smooth path forward for legislation to require more transparency in health care prices, and to change Medicare drug payments. The House Energy & Commerce Committee already introduced, held multiple hearings on, and unanimously passed out of committee a package of legislation including transparency requirements for hospitals and pharmacy b

Packaging 185

Packaging Hospitals 185

BioPharma Dive

JULY 17, 2023

Developers AstraZeneca and Sanofi expect to make the preventive antibody treatment, called Beyfortus, available ahead of the upcoming cold season.

95

95

STAT

JULY 17, 2023

A drug developed by the biotech firm BridgeBio to treat an increasingly common heart condition succeeded in its main goal in a clinical trial, the company said Monday, and also pointed to potential reductions in hospitalization and death. The results may give the medicine, acoramidis, a path to the market after a failure that led its maker’s stock to plunge in December 2021.

Hospitals 182

Hospitals Drug Development 182

Pharmaceutical Technology

JULY 17, 2023

The recent reintroduction of the Pasteur Act seeks to address the global threat that antimicrobial-resistant (AMR) infections pose, one subscription contract at a time.

86

86

Integra X Files

JULY 17, 2023

Creating and executing an effective marketing program for a pharmacy is easier if you’re armed with market research that reduces uncertainties about market characteristics, demographics, and economic opportunities. Fortunately, some (free) help is available from government sources. Maybe not free, exactly, because you’ve already paid for it when you write your regular check to the IRS.

Nursing Homes 84

Nursing Homes 84

Pharmaceutical Technology

JULY 17, 2023

The move follows a positive decision made by the EMA earlier this year, broadening the use of Veklury to the high-risk patient group.

98

98

Outsourcing Pharma

JULY 17, 2023

The U.S. startup Readout AI has closed a pre-seed financing round to fuel the development of an artificial intelligence (AI)-based tool to speed up data analysis in clinical trials.

98

98

Express Pharma

JULY 17, 2023

Sathgen aims to develop MSP008-22 for difficult-to-treat cancers, starting with triple negative breast cancer (TNBC) and prostate cancer as proof-of-principle Sathgen Therapeutics, a division of a leading chemical conglomerate in India – Godavari Biorefineries Limited (GBL), announced the completion of the first cohort in a Phase 1 clinical trial with their first-in-class New Chemical Entity (NCE), MSP008-22.

Chemotherapy 80

Chemotherapy 80

Outsourcing Pharma

JULY 17, 2023

Cumulus Neuroscience, a global digital health company focused on advancing neuroscience clinical trials and patient care, presented interim data from their first-in-class CNS-102 feasibility study at the European Network to Cure ALS Annual Meeting (ENCALS) in Barcelona, Spain.

98

98

Pharmaceutical Technology

JULY 17, 2023

The US Federal Court overturned a previous ruling in the patent infringement case against Rockefeller University.

98

98